(Q36693749)

15 August 2017

0 references

Modeling and simulation to optimize the design and analysis of confirmatory trials, characterize risk-benefit, and support label claims (English)

1 reference

15 August 2017

M Posch

5

0 references

Mats O Karlsson

4

object named as

M O Karlsson

1 reference

15 August 2017

S F Marshall

1

1 reference

15 August 2017

R Hemmings

2

1 reference

15 August 2017

F Josephson

3

1 reference

15 August 2017

J-L Steimer

6

1 reference

15 August 2017

27 February 2013

1 reference

CPT: pharmacometrics & systems pharmacology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

e27

1 reference

Modeling and simulation at the interface of nonclinical and early clinical drug development

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600757

Modeling and simulation as a tool to bridge efficacy and safety data in special populations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600757

Role of modelling and simulation: a European regulatory perspective.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600757

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600757

The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600757

Pharmacometrics for regulatory decision making: status and perspective

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FPSP.2013.4

Levodopa slows progression of Parkinson's disease: external validation by clinical trial simulation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FPSP.2013.4

31 March 2020

Identifiers

DOI

10.1038/PSP.2013.4

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23835938

1 reference